Page last updated: 2024-08-22

buthionine sulfoximine and Carcinoma, Lewis Lung

buthionine sulfoximine has been researched along with Carcinoma, Lewis Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banegas, I; Carmona-Cortés, J; García-Lora, AM; Quesada, A; Rodríguez-Gómez, I; Vargas, F; Vargas-Tendero, P; Wangensteen, R	1

Other Studies

1 other study(ies) available for buthionine sulfoximine and Carcinoma, Lewis Lung

Article	Year
The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activity. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014, Volume: 35, Issue:8 Topics: Aminopeptidases; Animals; Buthionine Sulfoximine; Carcinoma, Lewis Lung; Cells, Cultured; Male; Mice; Mice, Inbred CBA; Oxidative Stress; Protein Carbonylation; Thyroxine; Tubulin	2014

Article

Year

The pro-oxidant buthionine sulfoximine (BSO) reduces tumor growth of implanted Lewis lung carcinoma in mice associated with increased protein carbonyl, tubulin abundance, and aminopeptidase activity.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014, Volume: 35, Issue:8

Topics: Aminopeptidases; Animals; Buthionine Sulfoximine; Carcinoma, Lewis Lung; Cells, Cultured; Male; Mice; Mice, Inbred CBA; Oxidative Stress; Protein Carbonylation; Thyroxine; Tubulin

2014